SIMPHOTEK, INC.

NEWARK, NJ · Founded 2010 · CIK 0001513503 · Medtech · Private

DOSIE, a computational software system that calculates and optimizes light dose metrics (irradiance and fluence) for interstitial photodynamic therapy in real-time based on patient-specific tumor opti

simphotek.com →
Grants
$6.5M
9 awards
Sector median: 1
Raised
$1.1M
1 Form D · Feb 2011
187 months since last filing
Contracts
$755K
2 awards · Defense
#344 of 4531 in medtech
Patents
5
2 granted · 3 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal contractDepartment of Defense · (STTR FY08 Phase 2) Computer Aided Design For Rapid Development Of Novel Optical Materials And Sensor$749,998
Private capital raisedForm D · SEC$1,100,000
Federal contractDepartment of Defense · Perpetual License$5,500
Federal grantDepartment of Health and Human Services · Phase II · Development of Novel Fast GPU Monte Carlo and Active Photonics Simulation Software for Predicting PDT Efficacy$1,467,668
Federal grantDepartment of Health and Human Services · Phase I · Interstitial Intensity Modulated Photodynamic Therapy (i-IMPDT)$226,125
Federal grantDepartment of Health and Human Services · Phase II · Development of Novel Fast GPU Monte Carlo and Active Photonics Simulation Software for Predicting PDT Efficacy$717,468
Federal grantDepartment of Health and Human Services · Phase I · Interstitial Intensity Modulated Photodynamic Therapy (i-IMPDT)$50,000
Federal grantDepartment of Health and Human Services · Phase II · Interstitial Intensity Modulated Photodynamic Therapy Phase II$984,904
Federal grantDepartment of Health and Human Services · Phase II · Interstitial Intensity Modulated Photodynamic Therapy Phase II$980,701
Federal grantDepartment of Health and Human Services · Phase II · Interstitial Intensity Modulated Photodynamic Therapy Phase II$2,500
Federal grantDepartment of Health and Human Services · Phase II · Patient tailored near real-time image-based treatment for interstitial PDT of Inoperable Cancer with Airway Obstruction - Phase IIa$1,050,000
Federal grantDepartment of Health and Human Services · Phase II · Patient tailored near real-time image-based treatment for interstitial PDT of Inoperable Cancer with Airway Obstruction - Phase IIa$1,000,000
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
341BOOST TREADMILLS LLC$807K—
342Ninepoint Medical, Inc.$783K$70M
343GRADIENT HEALTH, INC.$766K$7.9M
344SIMPHOTEK, INC.$755K$1.1M
345NanoEngineering Corporation$753K$1.4M
346RESOURCEPATH LLC$750K—
347CHARLOT BIOSCIENCES INC$750K—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • Karl BeesonExecutive Officer
  • Archibald Cox, Jr.Director
  • Evgueni ParilovDirector · Executive Officer
  • Mary PotasekDirector · Executive Officer

Patents

USPTO · 2 granted of 5

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.